Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

MLA

Emery, P., et al. “Efficacy and Safety of Different Doses and Retreatment of Rituximab: A Randomised, Placebo-Controlled Trial in Patients Who Are Biological Naive with Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Study Evaluating Rituximab’s Efficacy in MTX INadequate REsponders (SERENE)).” Annals of the Rheumatic Diseases, vol. 69, no. 9, Sept. 2010, p. 1629. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.237667366&authtype=sso&custid=ns315887.

APA

Emery, P., Deodhar, A., Rigby, W. F., Isaacs, J. D., Combe, B., Racewicz, A. J., Latinis, K., Abud-Mendoza, C., Szczepanski, L. J., Roschmann, R. A., Chen, A., Armstrong, G. K., Douglass, W., & Tyrrell, H. (2010, September 1). Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab’s Efficacy in MTX iNadequate rEsponders (SERENE)). Annals of the Rheumatic Diseases, 69(9), 1629.

Chicago

Emery, P., A. Deodhar, W.F. Rigby, J.D. Isaacs, B. Combe, A.J. Racewicz, K. Latinis, et al. 2010. “Efficacy and Safety of Different Doses and Retreatment of Rituximab: A Randomised, Placebo-Controlled Trial in Patients Who Are Biological Naive with Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate (Study Evaluating Rituximab’s Efficacy in MTX INadequate REsponders (SERENE)).” Annals of the Rheumatic Diseases, September 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.237667366&authtype=sso&custid=ns315887.